His primary areas of study are Internal medicine, Psychiatry, Endocrinology, Schizophrenia and Psychosis. His study looks at the relationship between Internal medicine and topics such as Phospholipase A, which overlap with Acetylcholine and Cholinergic neuron. Wagner F. Gattaz usually deals with Psychiatry and limits it to topics linked to MEDLINE and Alternative medicine.
His Endocrinology research includes themes of Phospholipase A2, Phospholipid, Cerebrospinal fluid and Platelet. His Schizophrenia research is multidisciplinary, relying on both Proteome, Proteomics, Neuroplasticity, Neuroscience and Hypofrontality. He interconnects Cerebral cortex, Interferon gamma and Serum concentration in the investigation of issues within Psychosis.
His scientific interests lie mostly in Internal medicine, Endocrinology, Psychiatry, Schizophrenia and Disease. Wagner F. Gattaz works mostly in the field of Internal medicine, limiting it down to topics relating to Bipolar disorder and, in certain cases, Mood. His study focuses on the intersection of Endocrinology and fields such as Phospholipase A2 with connections in the field of Cell biology.
The Psychiatry study combines topics in areas such as Randomized controlled trial, MEDLINE and Clinical psychology. His Schizophrenia research incorporates themes from Haloperidol, Psychosis, Psychopathology and Neuroscience. His work on Disease deals in particular with Cognitive impairment and Dementia.
Wagner F. Gattaz mainly focuses on Internal medicine, Psychiatry, Bipolar disorder, Disease and Endocrinology. His study in Internal medicine is interdisciplinary in nature, drawing from both Hippocampal sclerosis, Oncology and Epilepsy. His work on Gastroenterology expands to the thematically related Psychiatry.
His Bipolar disorder study integrates concerns from other disciplines, such as Transcranial direct-current stimulation, Randomized controlled trial and Cognition. His work is dedicated to discovering how Randomized controlled trial, Schizophrenia are connected with White matter and Young adult and other disciplines. The concepts of his Disease study are interwoven with issues in Cancer research, Neuroimaging and Metabolism.
His primary areas of investigation include Internal medicine, Bipolar disorder, Psychiatry, Randomized controlled trial and Schizophrenia. He combines subjects such as Major depressive disorder, Drug-naïve and Endocrinology with his study of Internal medicine. His studies in Bipolar disorder integrate themes in fields like Dementia and Major depressive episode.
He focuses mostly in the field of Psychiatry, narrowing it down to matters related to Gastroenterology and, in some cases, Alzheimer's disease. His Randomized controlled trial study combines topics in areas such as Psychological intervention, Anesthesia, Hamilton Rating Scale for Depression, Physical therapy and Transcranial direct-current stimulation. His research integrates issues of White matter, Psychosis, Neuroscience and Audiology in his study of Schizophrenia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Search for the Causes of Schizophrenia
Heinz Häfner;Wagner Farid Gattaz.
(1987)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan;Peter Falkai;Thomas Wobrock;Jeffrey Lieberman.
World Journal of Biological Psychiatry (2012)
Mental Disorders in Megacities: Findings from the Sao Paulo Megacity Mental Health Survey, Brazil
Laura Helena Andrade;Yuan Pang Wang;Solange Andreoni;Camila Magalhães Silveira.
PLOS ONE (2012)
Causes and Consequences of the Gender Difference in Age at Onset of Schizophrenia
H Häfner;W an der Heiden;S Behrens;W F Gattaz.
Schizophrenia Bulletin (1998)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
Peter Falkai;Thomas Wobrock;Jeffrey Lieberman;Birte Glenthoj.
World Journal of Biological Psychiatry (2005)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
Alkomiet Hasan;Peter Falkai;Thomas Wobrock;Jeffrey Lieberman.
World Journal of Biological Psychiatry (2013)
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
Orestes V. Forlenza;Breno S. Diniz;Márcia Radanovic;Franklin S. Santos.
British Journal of Psychiatry (2011)
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder.
Paula V. Nunes;Orestes V. Forlenza;Wagner F. Gattaz.
British Journal of Psychiatry (2007)
Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
D P Hibar;L T Westlye;L T Westlye;N T Doan;N T Doan;N Jahanshad.
Molecular Psychiatry (2018)
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
Rajiv Tandon;R.H. Belmaker;Wagner F. Gattaz;Juan J. Lopez-Ibor.
Schizophrenia Research (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Universidade de São Paulo
The University of Texas Health Science Center at Houston
University of Zurich
Universidade de São Paulo
Universidade de São Paulo
Ludwig-Maximilians-Universität München
Universidade de São Paulo
National Institutes of Health
Centre for Addiction and Mental Health
Ludwig-Maximilians-Universität München
Centre national de la recherche scientifique, CNRS
Bar-Ilan University
University of Sheffield
University of Poitiers
University of Basel
Indian Institute of Technology Delhi
Zhengzhou University
Aarhus University
Chinese Academy of Sciences
Emory University
Chinese Academy of Sciences
Tongji University
University of Western Ontario
University of Tübingen
Osaka University
University of Toronto